Patient Professional
Contact Us
Podcast

Behind the Data: The Human Story Driving Gout Research

By: Ashia Lee, Director of Patient Education, Arthritis Foundation
Gout is one of the most treatable forms of arthritis. So why are so many people still suffering? This Gout Awareness Day – and throughout Arthritis Awareness Month – we went looking for answers.

What We’re Learning From Patients

Our recent Understanding Gout: An In-Depth Look at the Patient Experience report surveyed more than 400 people living with gout. What they shared was impossible to ignore.

  • 74% of patients said they were moderately or extremely concerned about their gout
  • 58% said the disease has a moderate or severe impact on their daily lives
  • Nearly half reported that gout significantly affects their emotional well-being
  • During flares, patients described struggling to move, sleep, work, and simply enjoy their lives

Despite this current reality, nearly half had never discussed urate-lowering therapy with their healthcare provider. More than a third had been living with gout for over 10 years. This is not simply a gap in care—it represents a missed opportunity to reduce preventable suffering. For too many patients, gout is being endured rather than actively managed to target.


The TRUST Trial—And Why It Matters

To help close the gap between evidence and practice, the Arthritis Foundation is supporting the TRUST Trial, which compares two approaches to gout management:

  • Treat-to-Target Serum Urate (T2T)
  • Treat-to-Avoid Symptoms (TTAS)

The trial also includes a biobank component, collecting biological samples to better understand the mechanisms that trigger gout flares. This foundational research has the potential to inform more precise, effective approaches to diagnosis and long-term management.

For clinicians, this work is critical to advancing evidence-based care. For patients, it represents an opportunity to contribute to research that may improve outcomes for future generations.

Gout Awareness Day is an opportunity to strengthen collaboration between patients and providers to address ongoing gaps in care. Survey findings make clear that many patients continue to experience a substantial disease burden while remaining under-informed about effective treatment options. Encouraging open dialogue, where patients feel empowered to raise concerns and providers proactively address both clinical and quality-of-life impacts is essential to improving outcomes. Expanding access to clear, patient-centered educational resources can further support understanding and engagement, while participation in clinical research, including studies like the TRUST Trial, ensures that future advances in gout management reflect real-world patient needs. Ultimately, progress in gout care depends on active partnership: informed patients, responsive providers, and continued investment in research working together to close the gap between evidence and experience.

Take the Next Step

Picture of Ashia Lee, Director of Patient Education, Arthritis Foundation

Ashia Lee, Director of Patient Education, Arthritis Foundation

Ashia Lee is a community-centered education and public health leader with over a decade of experience building programs and partnerships that meet people where they are. From Atlanta classrooms and city government to national health organizations, she has consistently shown up at the intersection of advocacy, equity, and action — turning big ideas into real resources for real communities.
Currently serving as Director of Patient Education at the Arthritis Foundation, Ashia leads education initiatives across 69 national markets with a commitment to ensuring every person, regardless of background, has the knowledge and support to live a healthier life. Holding a bachelor’s in Education and Masters in Organizational Leadership, her goal is to help every community, regardless of social or economic background, live healthier lives.

share